DE122007000051I1 - Kristallmodifikation von 1-(2,6-Difluorbenzyl)-1H-1,2,3,Triazol-4-Carbons{ureamid und seine Verwendung als Antiepileptikum - Google Patents
Kristallmodifikation von 1-(2,6-Difluorbenzyl)-1H-1,2,3,Triazol-4-Carbons{ureamid und seine Verwendung als AntiepileptikumInfo
- Publication number
- DE122007000051I1 DE122007000051I1 DE200712000051 DE122007000051C DE122007000051I1 DE 122007000051 I1 DE122007000051 I1 DE 122007000051I1 DE 200712000051 DE200712000051 DE 200712000051 DE 122007000051 C DE122007000051 C DE 122007000051C DE 122007000051 I1 DE122007000051 I1 DE 122007000051I1
- Authority
- DE
- Germany
- Prior art keywords
- ureamide
- antiepileptic
- difluorobenzyl
- triazole
- carboxylic acid
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
- C07D249/02—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
- C07D249/04—1,2,3-Triazoles; Hydrogenated 1,2,3-triazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pain & Pain Management (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Biomedical Technology (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CH140497 | 1997-06-10 | ||
PCT/EP1998/003427 WO1998056772A1 (en) | 1997-06-10 | 1998-06-08 | Crystal modification of 1-(2,6-difluorobenzyl)-1h-1,2,3--triazole-4-carboxamide and its use as antiepileptic |
Publications (2)
Publication Number | Publication Date |
---|---|
DE122007000051I1 true DE122007000051I1 (de) | 2007-11-08 |
DE122007000051I2 DE122007000051I2 (de) | 2009-02-19 |
Family
ID=4209650
Family Applications (3)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DE122007000051C Active DE122007000051I2 (de) | 1997-06-10 | 1998-06-08 | Kristallmodifikation von 1-(2,6-difluorbenzyl) -1h-1,2,3-triazol-4-carbonsäureamid und seine verwendung als antiepileptikum |
DE69813560T Expired - Lifetime DE69813560T2 (de) | 1997-06-10 | 1998-06-08 | Kristallmodifikation von 1-(2,6-difluorbenzyl)-1h-1,2,3-triazol-4-carbonsäureamid und seine verwendung als antiepileptikum |
DE69811500T Expired - Lifetime DE69811500T2 (de) | 1997-06-10 | 1998-06-08 | Kristallmodifikation von 1-(2,6-difluorbenzyl)-1h-1,2,3-triazol-4-carbonsäureamid und seine verwendung als antiepileptikum |
Family Applications After (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DE69813560T Expired - Lifetime DE69813560T2 (de) | 1997-06-10 | 1998-06-08 | Kristallmodifikation von 1-(2,6-difluorbenzyl)-1h-1,2,3-triazol-4-carbonsäureamid und seine verwendung als antiepileptikum |
DE69811500T Expired - Lifetime DE69811500T2 (de) | 1997-06-10 | 1998-06-08 | Kristallmodifikation von 1-(2,6-difluorbenzyl)-1h-1,2,3-triazol-4-carbonsäureamid und seine verwendung als antiepileptikum |
Country Status (37)
Country | Link |
---|---|
US (6) | US6740669B1 (de) |
EP (2) | EP0994864B1 (de) |
JP (2) | JP3672574B2 (de) |
KR (2) | KR100409168B1 (de) |
CN (3) | CN1298708C (de) |
AR (4) | AR012946A1 (de) |
AT (2) | ATE232852T1 (de) |
AU (2) | AU725517B2 (de) |
BR (2) | BR9804947A (de) |
CA (3) | CA2256015C (de) |
CO (2) | CO4940448A1 (de) |
CY (1) | CY2007014I2 (de) |
CZ (2) | CZ292260B6 (de) |
DE (3) | DE122007000051I2 (de) |
DK (2) | DK0994863T3 (de) |
ES (2) | ES2197485T3 (de) |
FR (1) | FR07C0037I2 (de) |
HK (3) | HK1028242A1 (de) |
HU (2) | HU225153B1 (de) |
ID (2) | ID21014A (de) |
IL (2) | IL125732A (de) |
LU (1) | LU91345I2 (de) |
MY (2) | MY125854A (de) |
NL (1) | NL300284I2 (de) |
NO (2) | NO329314B1 (de) |
NZ (2) | NZ331371A (de) |
PE (2) | PE79799A1 (de) |
PL (2) | PL191943B1 (de) |
PT (1) | PT994864E (de) |
RU (2) | RU2194041C2 (de) |
SI (2) | SI0994864T1 (de) |
SK (2) | SK283734B6 (de) |
TR (2) | TR199801631T1 (de) |
TW (2) | TW526195B (de) |
UY (1) | UY25844A1 (de) |
WO (2) | WO1998056772A1 (de) |
ZA (2) | ZA984967B (de) |
Families Citing this family (14)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
TW526195B (en) * | 1997-06-10 | 2003-04-01 | Novartis Ag | Crystal modifications of 1-(2,6-difluorobenzyl)-1H-1,2,3-triazole-4-carboxamide and their use |
AU2003249658A1 (en) * | 2002-05-31 | 2003-12-19 | Schering Corporation | Xanthine phosphodiesterase v inhibitor polymorphs |
GB0507298D0 (en) | 2005-04-11 | 2005-05-18 | Novartis Ag | Organic compounds |
US7875284B2 (en) * | 2006-03-10 | 2011-01-25 | Cook Incorporated | Methods of manufacturing and modifying taxane coatings for implantable medical devices |
US20090069390A1 (en) * | 2007-09-12 | 2009-03-12 | Protia, Llc | Deuterium-enriched rufinamide |
JP2012505191A (ja) | 2008-10-13 | 2012-03-01 | シプラ・リミテッド | ルフィナマイドの製造方法 |
CN101768124B (zh) * | 2008-12-30 | 2012-01-04 | 北京本草天源药物研究院 | 一种药物晶体及其制备方法和用途 |
IT1395736B1 (it) | 2009-08-04 | 2012-10-19 | Dipharma Francis Srl | Forme cristalline di rufinamide |
EP2963023B1 (de) * | 2009-09-04 | 2018-04-18 | Tactical Therapeutics, Inc. | Verfahren zur herstellung von 5-amino-1,2,3- triazol-orotat-derivaten |
US8884026B2 (en) | 2010-04-30 | 2014-11-11 | Laboratorios Lesvi, S.L. | Process for preparing rufinamide intermediate |
EP2465853A1 (de) | 2010-12-14 | 2012-06-20 | Laboratorios Lesvi, S.L. | Polymorph von Rufinamid und Verfahren zu seiner Herstellung |
ITMI20110718A1 (it) | 2011-04-29 | 2012-10-30 | Dipharma Francis Srl | Procedimento per la purificazione di rufinamide |
WO2014013511A2 (en) * | 2012-07-20 | 2014-01-23 | Hetero Research Foundation | Rufinamide solid dispersion |
WO2021099481A1 (en) | 2019-11-20 | 2021-05-27 | Medichem, S.A. | Solid composition containing rufinamide |
Family Cites Families (23)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3992378A (en) | 1973-12-26 | 1976-11-16 | Eli Lilly And Company | Fluoralkyl quinoxadinediones |
US4156734A (en) * | 1976-02-13 | 1979-05-29 | Merck & Co., Inc. | Antihypertensive compositions containing an aryl-substituted alanine azo and an arylhydrazino-propionic acid |
GB1511195A (en) | 1976-10-18 | 1978-05-17 | Ici America Inc | Triazole derivatives |
US4536518A (en) * | 1979-11-01 | 1985-08-20 | Pfizer Inc. | Antidepressant derivatives of cis-4-phenyl-1,2,3,4-tetrahydro-1-naphthalenamine |
US4346097A (en) * | 1980-09-30 | 1982-08-24 | Warner-Lambert Company | Method for treating convulsions with pyrazole-4-carboxamide derivatives |
FI834666A (fi) | 1982-12-23 | 1984-06-24 | Ciba Geigy Ag | Foerfarande foer framstaellning av nya aralkyltriazolfoereningar. |
US4789680A (en) * | 1982-12-23 | 1988-12-06 | Ciba-Geigy Corporation | Aralkyltriazole compounds |
US4511572A (en) * | 1983-03-18 | 1985-04-16 | The University Of Kentucky Research Foundation | Triazoline anticonvulsant drugs |
PH22568A (en) * | 1985-04-18 | 1988-10-17 | Ciba Geigy Ag | Fluorinated benzyl triazoles and pharmaceutical compositions containing the same |
CA2002864C (en) | 1988-11-29 | 1999-11-16 | Eddy J. E. Freyne | (1h-azol-1-ylmethyl) substituted quinoline, quinazoline or quinoxaline derivatives |
JPH02214504A (ja) | 1989-02-15 | 1990-08-27 | Nissan Chem Ind Ltd | 光学活性キノキサリン化合物の晶析法 |
WO1991001724A1 (en) | 1989-07-27 | 1991-02-21 | G.D. Searle & Co. | Renal-selective prodrugs for the treatment of hypertension |
IL96507A0 (en) | 1989-12-08 | 1991-08-16 | Merck & Co Inc | Nitrogen-containing spirocycles and pharmaceutical compositions containing them |
AU656154B2 (en) | 1990-11-06 | 1995-01-27 | Astellas Pharma Inc. | Fused pyrazine derivative |
JP2753911B2 (ja) | 1991-12-06 | 1998-05-20 | キッセイ薬品工業株式会社 | N−tert−ブチル−1−メチル−3,3−ジフェニルプロピルアミン塩酸塩の結晶多形およびその製造方法 |
DE4217952A1 (de) | 1992-05-30 | 1993-12-02 | Basf Ag | Chinoxalin-2,3(1H,4H)-dione |
US5248699A (en) * | 1992-08-13 | 1993-09-28 | Pfizer Inc. | Sertraline polymorph |
US5631373A (en) | 1993-11-05 | 1997-05-20 | State Of Oregon, Acting By And Through The Oregon State Board Of Higher Education, Acting For And On Behalf Of The Oregon Health Sciences University And The University Of Oregon, Eugene Oregon | Alkyl, azido, alkoxy, and fluoro-substituted and fused quinoxalinediones |
GB9418443D0 (en) | 1994-09-13 | 1994-11-02 | Pfizer Ltd | Therapeutic agents |
GB9419318D0 (en) | 1994-09-24 | 1994-11-09 | Pfizer Ltd | Therapeutic agents |
KR100419355B1 (ko) | 1995-02-22 | 2004-06-04 | 훽스트파마슈티칼스앤드케미칼스가부시키가이샤 | 무정형피레타나이드,피레타나이드다형체,이들의제조방법및이를포함하는약제학적조성물 |
BR9710252B1 (pt) * | 1996-07-11 | 2010-06-29 | processo para preparar4 4-ciano-1,2,3-triazóis 1-substituìdos. | |
TW526195B (en) * | 1997-06-10 | 2003-04-01 | Novartis Ag | Crystal modifications of 1-(2,6-difluorobenzyl)-1H-1,2,3-triazole-4-carboxamide and their use |
-
1998
- 1998-06-04 TW TW087108858A patent/TW526195B/zh not_active IP Right Cessation
- 1998-06-04 TW TW087108859A patent/TW403740B/zh not_active IP Right Cessation
- 1998-06-08 AT AT98934929T patent/ATE232852T1/de active
- 1998-06-08 AU AU84372/98A patent/AU725517B2/en not_active Expired
- 1998-06-08 IL IL12573298A patent/IL125732A/en not_active IP Right Cessation
- 1998-06-08 ES ES98934930T patent/ES2197485T3/es not_active Expired - Lifetime
- 1998-06-08 DK DK98934929T patent/DK0994863T3/da active
- 1998-06-08 CZ CZ19982534A patent/CZ292260B6/cs not_active IP Right Cessation
- 1998-06-08 PL PL330764A patent/PL191943B1/pl unknown
- 1998-06-08 SI SI9830450T patent/SI0994864T1/xx unknown
- 1998-06-08 CN CNB2004100473675A patent/CN1298708C/zh not_active Expired - Lifetime
- 1998-06-08 BR BR9804947A patent/BR9804947A/pt not_active Application Discontinuation
- 1998-06-08 PE PE1998000478A patent/PE79799A1/es not_active IP Right Cessation
- 1998-06-08 JP JP53628898A patent/JP3672574B2/ja not_active Expired - Lifetime
- 1998-06-08 TR TR1998/01631T patent/TR199801631T1/xx unknown
- 1998-06-08 WO PCT/EP1998/003427 patent/WO1998056772A1/en active IP Right Grant
- 1998-06-08 PT PT98934930T patent/PT994864E/pt unknown
- 1998-06-08 KR KR10-1998-0708149A patent/KR100409168B1/ko not_active IP Right Cessation
- 1998-06-08 IL IL12573398A patent/IL125733A/en active Protection Beyond IP Right Term
- 1998-06-08 SI SI9830405T patent/SI0994863T1/xx unknown
- 1998-06-08 SK SK1094-98A patent/SK283734B6/sk not_active IP Right Cessation
- 1998-06-08 NZ NZ331371A patent/NZ331371A/xx not_active IP Right Cessation
- 1998-06-08 CN CN988000113A patent/CN1132820C/zh not_active Expired - Lifetime
- 1998-06-08 DE DE122007000051C patent/DE122007000051I2/de active Active
- 1998-06-08 HU HU0002113A patent/HU225153B1/hu unknown
- 1998-06-08 TR TR1998/01630T patent/TR199801630T1/xx unknown
- 1998-06-08 SK SK1093-98A patent/SK283685B6/sk not_active IP Right Cessation
- 1998-06-08 DE DE69813560T patent/DE69813560T2/de not_active Expired - Lifetime
- 1998-06-08 US US09/125,329 patent/US6740669B1/en not_active Expired - Lifetime
- 1998-06-08 PE PE1998000479A patent/PE80999A1/es not_active IP Right Cessation
- 1998-06-08 EP EP98934930A patent/EP0994864B1/de not_active Expired - Lifetime
- 1998-06-08 CA CA002256015A patent/CA2256015C/en not_active Expired - Lifetime
- 1998-06-08 ID IDW980066D patent/ID21014A/id unknown
- 1998-06-08 NZ NZ331370A patent/NZ331370A/xx not_active IP Right Cessation
- 1998-06-08 EP EP98934929A patent/EP0994863B1/de not_active Expired - Lifetime
- 1998-06-08 CZ CZ19982533A patent/CZ292481B6/cs not_active IP Right Cessation
- 1998-06-08 DK DK98934930T patent/DK0994864T3/da active
- 1998-06-08 RU RU99104299/04A patent/RU2194041C2/ru active
- 1998-06-08 ES ES98934929T patent/ES2192779T3/es not_active Expired - Lifetime
- 1998-06-08 WO PCT/EP1998/003428 patent/WO1998056773A1/en active IP Right Grant
- 1998-06-08 CA CA002256013A patent/CA2256013C/en not_active Expired - Lifetime
- 1998-06-08 JP JP53628998A patent/JP3672575B2/ja not_active Expired - Lifetime
- 1998-06-08 PL PL330798A patent/PL192114B1/pl unknown
- 1998-06-08 CA CA2614926A patent/CA2614926C/en not_active Expired - Lifetime
- 1998-06-08 DE DE69811500T patent/DE69811500T2/de not_active Expired - Lifetime
- 1998-06-08 RU RU99104300/04A patent/RU2198167C2/ru active
- 1998-06-08 ID IDW980065D patent/ID27660A/id unknown
- 1998-06-08 AU AU84371/98A patent/AU725528B2/en not_active Expired
- 1998-06-08 KR KR10-1998-0708150A patent/KR100425656B1/ko not_active IP Right Cessation
- 1998-06-08 AT AT98934930T patent/ATE237599T1/de active
- 1998-06-08 BR BR9804946A patent/BR9804946A/pt not_active Application Discontinuation
- 1998-06-08 HU HU0000798A patent/HU226107B1/hu unknown
- 1998-06-08 CN CNB988056755A patent/CN1159300C/zh not_active Expired - Lifetime
- 1998-06-09 ZA ZA984967A patent/ZA984967B/xx unknown
- 1998-06-09 CO CO98032885A patent/CO4940448A1/es unknown
- 1998-06-09 AR ARP980102708A patent/AR012946A1/es not_active Application Discontinuation
- 1998-06-09 MY MYPI98002572A patent/MY125854A/en unknown
- 1998-06-09 ZA ZA984966A patent/ZA984966B/xx unknown
- 1998-06-09 CO CO98032879A patent/CO4940452A1/es unknown
- 1998-06-09 MY MYPI98002570A patent/MY120156A/en unknown
- 1998-06-09 AR ARP980102707A patent/AR012945A1/es not_active Application Discontinuation
- 1998-08-11 NO NO19983666A patent/NO329314B1/no not_active IP Right Cessation
- 1998-08-11 NO NO19983667A patent/NO329315B1/no not_active IP Right Cessation
-
1999
- 1999-12-10 UY UY25844A patent/UY25844A1/es not_active Application Discontinuation
-
2000
- 2000-10-25 HK HK00106807A patent/HK1028242A1/xx not_active IP Right Cessation
- 2000-10-25 HK HK00106804A patent/HK1028241A1/xx not_active IP Right Cessation
- 2000-11-17 HK HK00107340A patent/HK1028031A1/xx not_active IP Right Cessation
-
2001
- 2001-05-31 US US09/871,366 patent/US6455556B2/en not_active Expired - Lifetime
-
2002
- 2002-11-14 US US10/294,408 patent/US20030125568A1/en not_active Abandoned
-
2004
- 2004-02-26 US US10/787,528 patent/US20040167186A1/en not_active Abandoned
-
2006
- 2006-01-11 US US11/329,945 patent/US7750028B2/en not_active Expired - Fee Related
-
2007
- 2007-05-17 AR ARP070102131A patent/AR061004A2/es unknown
- 2007-05-17 AR ARP070102132A patent/AR061005A2/es not_active Application Discontinuation
- 2007-07-03 NL NL300284C patent/NL300284I2/nl unknown
- 2007-07-04 LU LU91345C patent/LU91345I2/fr unknown
- 2007-07-06 FR FR07C0037C patent/FR07C0037I2/fr active Active
- 2007-07-13 CY CY200700014C patent/CY2007014I2/el unknown
-
2010
- 2010-04-26 US US12/767,003 patent/US8076362B2/en not_active Expired - Fee Related
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DE122007000051I1 (de) | Kristallmodifikation von 1-(2,6-Difluorbenzyl)-1H-1,2,3,Triazol-4-Carbons{ureamid und seine Verwendung als Antiepileptikum | |
ATE202347T1 (de) | Aminothiophencarbonsäureamide und ihre verwendung als phosphodiesterase inhibitoren | |
DE59403814D1 (de) | Substituierte Triazolinone sowie ihre Verwendung als Herbizide | |
DE69629670D1 (de) | Lactam-enthaltende hydroxamsäure-derivate, deren herstellung und deren verwendung als inhibitoren von matrix-metalloproteasen | |
DE59608154D1 (de) | Verwendung von polyasparaginsäureamiden als lederhilfsmittel | |
ATE232207T1 (de) | N-triazolyl-2-indolcarbonsäureamide und ihre verwendung als cck-a agonisten | |
DE69628195D1 (de) | Verwendung von xyloglucanendotransglycosylase | |
DE69616944D1 (de) | Verwendung von des-aspartat-angiotensin i als wirkstoff gegen herzhypertrophie | |
ATE271313T1 (de) | Verwendung von pyrrolverbindungen als antifouling-wirkstoff | |
ATE181071T1 (de) | Piperidinessigsäurederivate und ihre verwendung als fibrinogenantagonistmittel | |
ATE221529T1 (de) | Oxadiazolinderivate und ihre verwendung als insektizide | |
DE69531048D1 (de) | Verwendung von steroidsulphatase-hemmern | |
DE69333362D1 (de) | Verwendung von angiotensin antagonisten (at1) zur verminderung des erkrankungs- und todesfallrisikos nach myokardinfarkt | |
ATE233569T1 (de) | Verwendung von proteine als mittel gegen autoimmunekrankheiten | |
DE69421235T2 (de) | Amidrazone und ihre Verwendung als Pestizide | |
DE59407240D1 (de) | Substituierte azadioxacycloalkene und ihre verwendung als fungizide | |
DE69505124T2 (de) | Verwendung von dibutylmalat als insektenlockstoff | |
DE59610382D1 (de) | Halogenbenzimidazole und ihre verwendung als mikrobizide | |
DE1229027T1 (de) | Heterocyclische N-Acetonylbenzamide und ihre Verwendung als Fungizide | |
DE69616760T2 (de) | Verwendung von 4-tert-butyl-1-cyclohexanol als antioxidant | |
TH9801002100B (th) | รูปแบบโครงสร้างผลึกดัดแปลงของ 1-(2,6-ไดฟลูออโรเบนซิล)-1h-1,2,3-ไตรอาโซล-4-คาร์บอกซาไมด์ | |
TR199800920A2 (xx) | Transjenik insan d��� hayvanlardan kopyalama komplekslerinin safla�t�r�lmas�. | |
ATE218343T1 (de) | Verwendung von substituierten und nichtsubstituierten n-(pyrrol-1-yl)pyridinaminen als antikonvulsiva | |
DE59912335D1 (de) | Verwendung von tricyclischen aldehyden als riechstoffe | |
DE59408603D1 (de) | Substituierte Triazolinone sowie ihre Verwendung als Herbizide |